Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SEC-Like Agency Would Bring Transparency To Healthcare – Herzlinger

This article was originally published in The Gray Sheet

Executive Summary

Harvard Business School Professor Regina Herzlinger advocates a Securities and Exchange Commission-style agency to foster price and outcomes transparency within healthcare

You may also be interested in...



Hospital price data published

CMS posts payment information on its website for the 30 most common elective procedures and reasons for admissions, including implantation of defibrillators and hip and knee replacements. Posted June 1 to kick off the agency's transparency initiative, the data shows the service volumes and Medicare payment ranges for all hospitals by county to help consumers compare price and quality of care (1"The Gray Sheet" March 20, 2006, p. 13). The agency plans to add geographically based payment information for ambulatory surgery centers this summer, and outpatient and physician services in the fall...

Device Industry Aims To Prevent Image Problems That Have Plagued Pharma

Recent polling data commissioned by AdvaMed suggest that medical devices, if not the industry itself, are still in relative good graces with the public, but that clear vulnerabilities exist

ECHA Deliberates On Final Microplastic Proposal As Beauty Industry’s Fate Hangs In Balance

A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.

UsernamePublicRestriction

Register

OM009163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel